The role of coronavirus infection (COVID-19) in the development of systemic vasculitis

Abstract

The scientific article presents data on the effect of coronavirus infection on the development of systemic vasculitis. The study of options for clinical trials of systemic vasculitis in patients with coronavirus infection necessarily necessitates the use of alternative treatment tactics in time for this disease, and as a result, complications of the disease are prevented, and in patients with a complicated or chronic form of the disease, the transition of the disease in a mild form and a significant decrease in This assesses how significant medicamentous therapy is. The Prevention of risk factors, analysis of the clinical course of systemic vasculitis and changes in laboratory-instrumental examinations serve to identify the disease in time, reduce the risk of its complications for a while, and bring the lethality rate to a minimum. The results of scientific research are recommended for use in the activities of doctors. The results obtained are recommended for use in the process of teaching students of medical institutes.